Terzi, M. Et Al. 2016. Real-life data from efficacy of fingolimod treatment in multiple sclerosis patients in Turkey. 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) , (London, Canada), 310.

Terzi, M., Kurtuncu, M., Eraksoy, M., Karabudak, R., Tuncer, A., Altunrende, B., ... Akcali, A.(2016). Real-life data from efficacy of fingolimod treatment in multiple sclerosis patients in Turkey . 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) (pp.310). London, Canada

Terzi, M. Et Al. "Real-life data from efficacy of fingolimod treatment in multiple sclerosis patients in Turkey," 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), London, Canada, 2016

Terzi, M. Et Al. "Real-life data from efficacy of fingolimod treatment in multiple sclerosis patients in Turkey." 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) , London, Canada, pp.310, 2016

Terzi, M. Et Al. (2016) . "Real-life data from efficacy of fingolimod treatment in multiple sclerosis patients in Turkey." 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) , London, Canada, p.310.

@conferencepaper{conferencepaper, author={M. Terzi Et Al. }, title={Real-life data from efficacy of fingolimod treatment in multiple sclerosis patients in Turkey}, congress name={32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)}, city={London}, country={Canada}, year={2016}, pages={310} }